Geremy clair
banner
geremyclair.bsky.social
Geremy clair
@geremyclair.bsky.social
Biomedical Scientist using spatial omics to understand cellular and molecular interactions in pulmonary and kidney diseases.
🚀 Off the press! Deep generative AI and multi-omics datasets are revolutionizing drug screening. Check out the findings here: www.nature.com/articles/s41.... It was incredible to be part of this endeavor. Learn more about UNAGI here🐡 🐍: medicine.yale.edu/news-article... @kaminskimed.bsky.social
A deep generative model for deciphering cellular dynamics and in silico drug discovery in complex diseases - Nature Biomedical Engineering
UNAGI deciphers cellular dynamics from human disease time-series single-cell data and facilitates in silico drug perturbations to discover drugs potentially active against complex human diseases.
www.nature.com
June 20, 2025 at 8:43 PM
New publication 🫁 📊 🔬 ! We performed proteomics and transcriptomics of lung sorted cells from human (0 to 8 years). We discovered new cell markers and pathway modulated during development. A must-read for #teamMassSpec enthusiasts focused on development www.atsjournals.org/doi/abs/10.1...
Increased Pulmonary GM-CSF Causes Alveolar Macrophage Accumulation. Mechanistic Implications for Desquamative Interstitial Pneumonitis
www.atsjournals.org
December 6, 2024 at 6:08 PM
🚨 Exciting new research alert! We're thrilled to have contributed to this work that uncovers the role of EMC3 in managing the SFTPCI73T mutation linked to interstitial lung disease and the role of other genes such as EMC3 and VCP in surfactant trafficking www.jci.org/articles/vie... (a thread 1/4)
JCI - EMC3 regulates trafficking and pulmonary toxicity of the SFTPCI73T mutation associated with interstitial lung disease
www.jci.org
December 3, 2024 at 4:53 PM